Companies: 10,795·Total market cap: $144.5T
Psyence Biomedical Ltd.

Psyence Biomedical Ltd.

PBMNASDAQHealthcare● Active
$3.60
+$0.09(+2.56%)
Market Cap$68468
P/E Ratio
52W High$468.35938
52W Low$1.92

Psyence Biomedical Ltd. (PBM) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · PBM · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-032024-032023-032022-03
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)($0.00B)$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.00B$0.00B$0.00B$0.00B
Operating Income($0.00B)($0.00B)($0.00B)($0.00B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.00B($0.05B)$0.01B$0.01B
Income Tax Expense$0.00B$0.00B$0.00B$0.00B
Net Income$0.00B($0.05B)$0.01B$0.01B
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$1.78$-7.85$-0.64$0.25
Wtd Avg Shares0.00B0.01B0.03B0.03B
EBITDA$0.00B($0.05B)$0.01B$0.01B
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B

Explore more Psyence Biomedical Ltd. data

About Psyence Biomedical Ltd. (PBM) Income Statement

Psyence Biomedical Ltd. (PBM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PBM reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of $0.00B — a net profit margin of —.

Frequently asked questions

PBM · 4 questions

Psyence Biomedical Ltd. (PBM) reported revenue of $0.00B for 2025, down —% year-over-year.

PBM revenuePBM salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09